Adipose-Derived Stem Cell Exosomes Attenuated Fibroblast Senescence By Regulating Endoplasmic Reticulum Stress Through Sirt1

Therapeutic
Aging Pathway
Analytical
Adipose-derived stem cell exosomes can inhibit the aging of fibroblasts by managing stress within the cells’ protein-making machinery through the action of a protein called SIRT1.
Author

Gemini

Published

February 1, 2026

Our bodies contain specialized cells called fibroblasts, which are crucial for maintaining healthy tissues, especially in the skin. As we age, these fibroblasts can enter a state called senescence, where they stop dividing and can even contribute to further aging and age-related conditions. This process is often linked to stress within a cell’s “protein factory,” known as the endoplasmic reticulum (ER). When the ER is overwhelmed, it can lead to cellular dysfunction.

Recent research has shed light on a potential way to combat this cellular aging using tiny messengers called exosomes, which are released by adipose-derived stem cells (ADSCs). ADSCs are adult stem cells found in fat tissue, known for their regenerative abilities. Exosomes are like miniature packages that carry important proteins and genetic material between cells.

This study found that exosomes from ADSCs can effectively reduce fibroblast senescence. They achieve this by helping to regulate the stress in the ER, and a key player in this beneficial effect is a protein called SIRT1. SIRT1 is known to be involved in various cellular processes, including aging and stress responses. By modulating SIRT1, these exosomes help fibroblasts to continue multiplying, prevent their premature death, and maintain proper collagen production, all of which are vital for tissue health.

These findings suggest that harnessing the power of these stem cell-derived exosomes could offer new avenues for understanding and potentially developing treatments to slow down cellular aging and improve tissue regeneration.


Source: link to paper